SYDNEE KERN: Open Payments
NPI 1619638285 · KERRVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 63 payments from 15 companies in 2025. Trend: 2023 $501 · 2024 $675 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $236 |
| Janssen Biotech, Inc. | 15 | $225 |
| Madrigal Pharmaceuticals | 7 | $223 |
| GENZYME CORPORATION | 4 | $101 |
| Ipsen Biopharmaceuticals, Inc | 4 | $89 |
| PFIZER INC. | 4 | $80 |
| Gilead Sciences, Inc. | 3 | $71 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Ardelyx, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: TREMFYA, REZDIFFRA, MAVYRET, DUPIXENT, IQIRVO, XELJANZ, CREON, RINVOQ.
Industry payments across TX — which companies pay providers there.
